Skip to content

Now let me review the GO-CAM model with all the information I have gathered:

GO-CAM Model Review: EGFR Signaling Pathway (gomodel:61e0e55600000430)

Overview

This GO-CAM model (gomodel:61e0e55600000430) represents the "Epidermal growth factor receptor signaling pathway 11 (Mouse)" within the context of mouse (NCBITaxon:10090). The model was sourced from gomodel:R-HSA-212718 and includes automated updates to certain relation terms.

Model Structure

The model contains the following key components:

  1. EGF (MGI:MGI:95290) - acts as a ligand with receptor ligand activity (GO:0048018)
  2. EGFR (MGI:MGI:95294) - has two functions:
  3. Epidermal growth factor receptor activity (GO:0005006)
  4. Protein tyrosine kinase activity (GO:0004713)
  5. PLCγ1 (MGI:MGI:97615) - has phospholipase C activity (GO:0004629)

The model shows a causal chain where: - EGF directly positively regulates (RO:0002629) EGFR receptor activity - EGFR receptor activity directly positively regulates (RO:0002629) EGFR kinase activity - EGFR kinase activity directly positively regulates (RO:0002629) PLCγ1 phospholipase C activity

Evaluation

Strengths of the model:

  1. Correct core elements: The model correctly identifies the key components of EGFR signaling - the EGF ligand, EGFR receptor, and PLCγ1 as a downstream effector.

  2. Appropriate molecular functions: Each gene product is annotated with appropriate molecular functions based on their biological roles.

  3. Accurate causal relationships: The model uses the "directly positively regulates" (RO:0002629) relation to show how the pathway flows from EGF to EGFR activation to PLCγ1 activation, which is supported by literature.

  4. Correct cellular compartmentalization: The model properly places EGF in the extracellular space (GO:0005615) and both EGFR and PLCγ1 at the plasma membrane (GO:0005886).

  5. Association with biological process: All activities are correctly associated with the epidermal growth factor receptor signaling pathway (GO:0007173).

Issues and Recommendations:

  1. Missing intermediate mechanistic steps: The model does not explicitly capture that EGFR first autophosphorylates after ligand binding, creating docking sites for PLCγ1's SH2 domains. EGFR then phosphorylates PLCγ1, activating its phospholipase activity. These intermediate steps would provide a more complete mechanistic picture.

  2. Missing downstream effects: The model doesn't include the consequences of PLCγ1 activation - hydrolyzing PIP2 to produce IP3 and DAG, which then activate calcium release and PKC, respectively.

  3. Missing other key EGFR signaling branches: The model focuses only on the PLCγ1 pathway but doesn't include other important EGFR downstream pathways like RAS/MAPK, PI3K/AKT, or STAT pathways.

  4. Evidence evaluation: The evidence seems appropriate, as it comes from a mixture of experimental evidence codes and orthology-based evidence.

Biological Accuracy Assessment

From a biological standpoint, the model correctly captures a simplified view of EGFR activation of PLCγ1. Based on the UniProt entries and literature evidence:

  1. EGF is indeed a ligand that binds to and activates EGFR
  2. EGFR does function as both a receptor and a tyrosine kinase
  3. EGFR does directly phosphorylate and activate PLCγ1
  4. The cellular locations are accurate

The PMID:28004780 reference provides strong evidence for the connection between EGFR, PLCγ1, and PKC pathways in epidermal differentiation, supporting the model's representation of EGFR activating PLCγ1. The PMID:9529375 reference confirms that PLCγ1 is activated downstream of EGFR, although it suggests that PLCγ1 may not be essential for all EGFR-mediated cellular responses, particularly mitogenesis in fibroblasts.

Conclusion

This is a biologically accurate but simplified model of EGFR signaling focused specifically on PLCγ1 activation. The model follows GO-CAM best practices for signaling receptor annotation. The model correctly represents the causal chain from EGF to EGFR to PLCγ1, with appropriate molecular functions and cellular locations.

To improve the model, additional mechanistic details could be added, such as the phosphorylation events that mediate EGFR activation of PLCγ1, and downstream effects of PLCγ1 activation (IP3/DAG production leading to calcium release and PKC activation). Additionally, including other major branches of EGFR signaling would provide a more comprehensive view of this pathway.